Literature DB >> 29955972

Comparison of the horizontal diameter to a modeled area of traction in eyes with vitreomacular traction: is the diameter close enough to the truth?

Christoph Paul1, P Krug2, H H Müller3, J Wachtlin4,5, S Mennel6, S Müller7, S Schmitz-Valckenberg7, T Bertelmann2,8, R G Schumann9.   

Abstract

PURPOSE: In daily practice, vitreomacular traction (VMT) is described by the horizontal diameter of its attachment site implying a regular round shape of VMT. We investigated the deviation from this circular area of vitreous traction in patients with VMT.
METHODS: A retrospective analysis of optical coherence tomography (OCT) scans was performed. The area of vitreomacular attachment was determined using six radial OCT scans (Ameasured). The assumed circular area of traction was calculated based on measuring the maximal horizontal diameter for comparison (Acircular).
RESULTS: Thirty-seven eyes of 37 patients with pure VMT were included. Patients' mean age was 72.8 ± 8.2 years. Mean horizontal VMT diameter was 400.8 ± 230.5 μm (median 361 μm; range 44-991 μm). While there was no difference between mean areas of traction for Acircular and Ameasured (P = 0.93), the individual difference (|Acircular - Ameasured|) was 0.042 (± 0.044) mm2 in mean or relative 73.0% (± 135.8%). A difference of ≥ 30% of Ameasured to Acircular was found in 16 eyes (43.2%) and ≥ 100% in 7 eyes (18.9%), respectively.
CONCLUSION: Vitreous attachment sites possess an irregular non-circular shape in a significant number of eyes with VMT. Consequently, the area of traction appears inaccurately described by its horizontal VMT diameter alone. As the area of traction is important for therapeutic recommendation, our results emphasize the need for a more precise description of the area of traction in eyes with VMT.

Entities:  

Keywords:  Area of traction; Horizontal diameter; Optical coherence tomography; Vitreomacular attachment; Vitreomacular traction (VMT); Vitreous attachment sites

Mesh:

Year:  2018        PMID: 29955972     DOI: 10.1007/s00417-018-4055-0

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  20 in total

1.  Three-dimensional evaluation of vitreomacular traction and epiretinal membrane using spectral-domain optical coherence tomography.

Authors:  Hideki Koizumi; Richard F Spaide; Yale L Fisher; K Bailey Freund; James M Klancnik; Lawrence A Yannuzzi
Journal:  Am J Ophthalmol       Date:  2008-01-11       Impact factor: 5.258

2.  Calculating the individual probability of successful ocriplasmin treatment in eyes with VMT syndrome: a multivariable prediction model from the EXPORT study.

Authors:  Christoph Paul; Christine Heun; Hans-Helge Müller; Hans Hoerauf; Nicolas Feltgen; Joachim Wachtlin; Hakan Kaymak; Stefan Mennel; Michael Janusz Koss; Sascha Fauser; Mathias M Maier; Ricarda G Schumann; Simone Mueller; Petrus Chang; Steffen Schmitz-Valckenberg; Sara Kazerounian; Peter Szurman; Albrecht Lommatzsch; Thomas Bertelmann
Journal:  Br J Ophthalmol       Date:  2017-10-31       Impact factor: 4.638

3.  Three-dimensional reconstruction and analysis of vitreomacular traction: quantification of cyst volume and vitreoretinal interface area.

Authors:  Grant D Aaker; Luis Gracia; Jane S Myung; Vanessa Borcherding; Jason R Banfelder; Donald J D'Amico; Szilárd Kiss
Journal:  Arch Ophthalmol       Date:  2011-06

4.  Rate and timing of spontaneous resolution in a vitreomacular traction group: should the role of watchful waiting be re-evaluated as an alternative to ocriplasmin therapy?

Authors:  Spyridon Dimopoulos; Karl-Ulrich Bartz-Schmidt; Faik Gelisken; Kai Januschowski; Focke Ziemssen
Journal:  Br J Ophthalmol       Date:  2014-10-23       Impact factor: 4.638

5.  A novel spectral-domain optical coherence tomography model to estimate changes in vitreomacular traction syndrome.

Authors:  Marco Codenotti; Lorenzo Iuliano; Giovanni Fogliato; Giuseppe Querques; Francesco Bandello
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-04-25       Impact factor: 3.117

6.  Spontaneous resolution of vitreomacular traction demonstrated by spectral-domain optical coherence tomography.

Authors:  George P Theodossiadis; Vlassis G Grigoropoulos; Sofia Theodoropoulou; Ioannis Datseris; Panagiotis G Theodossiadis
Journal:  Am J Ophthalmol       Date:  2014-01-18       Impact factor: 5.258

7.  Real-life experience after intravitreal ocriplasmin for vitreomacular traction and macular hole: a spectral-domain optical coherence tomography prospective study.

Authors:  Irini Chatziralli; George Theodossiadis; Efstratios Parikakis; Ioannis Datseris; Panagiotis Theodossiadis
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-05-05       Impact factor: 3.117

8.  Long-term evaluation of vitreomacular traction disorder in spectral-domain optical coherence tomography.

Authors:  Dominik Odrobina; Zofia Michalewska; Janusz Michalewski; Krzysztof Dzięgielewski; Jerzy Nawrocki
Journal:  Retina       Date:  2011-02       Impact factor: 4.256

9.  A retrospective cohort study in patients with tractional diseases of the vitreomacular interface (ReCoVit).

Authors:  Peter Stalmans
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-02-22       Impact factor: 3.117

10.  PNEUMATIC VITREOLYSIS FOR RELIEF OF VITREOMACULAR TRACTION.

Authors:  Clement K Chan; Jason N Crosson; Calvin E Mein; Noha Daher
Journal:  Retina       Date:  2017-10       Impact factor: 4.256

View more
  3 in total

1.  Comment re: Comparison of the horizontal diameter to a modeled area of traction in eyes with vitreomacular traction: is the diameter close enough to the truth?

Authors:  Sofia Theodoropoulou; George P Theodossiadis; Vlassis G Grigoropoulos; Panagiotis G Theodossiadis
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-08-25       Impact factor: 3.117

Review 2.  Patient-reported outcomes of ocriplasmin for the treatment of vitreomacular traction: a systematic review and synthesis of the literature.

Authors:  Benedicte Lescrauwaet; Koenraad Blot; Timothy L Jackson
Journal:  Patient Relat Outcome Meas       Date:  2019-03-27

3.  Calculating the individual probability of successful ocriplasmin treatment in eyes with vitreomacular traction-Validation and refinement of a multivariable prediction model.

Authors:  Christoph Paul; Hans-Helge Müller; Thomas Raber; Thomas Bertelmann
Journal:  PLoS One       Date:  2022-07-25       Impact factor: 3.752

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.